Thomas Powell

2.8k total citations · 1 hit paper
31 papers, 2.4k citations indexed

About

Thomas Powell is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Thomas Powell has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Thomas Powell's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Respiratory viral infections research (7 papers). Thomas Powell is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Respiratory viral infections research (7 papers). Thomas Powell collaborates with scholars based in United States, United Kingdom and France. Thomas Powell's co-authors include Cho Tang, Laura K. Shawver, Randall Schreck, K. Peter Hirth, A. Ullrich, Gerald McMahon, Jie Tang, T. Annie T. Fong, Li Sun and Xueyan Wang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Thomas Powell

31 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

1999 885 citations Thomas Powell, Randall Schreck et al. profile →

Peers

Countries citing papers authored by Thomas Powell

Since Specialization

Citations

This map shows the geographic impact of Thomas Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Powell more than expected).

Fields of papers citing papers by Thomas Powell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Powell. The network helps show where Thomas Powell may publish in the future.

Co-authorship network of co-authors of Thomas Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Powell. A scholar is included among the top collaborators of Thomas Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Powell. Thomas Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of Isopeptide Bonds in Monoclonal Antibody Aggregates 2021 ·Pharmaceutical Research ·Thomas Powell, Michael Knight, (unknown), John O’Hara, William Burkitt	2
2	Photoinduced cross-linking of formulation buffer amino acids to monoclonal antibodies 2021 ·European Journal of Pharmaceutics and Biopharmaceutics ·Thomas Powell, Michael Knight, (unknown), John O’Hara, William Burkitt	9
3	Raman Spectroscopy to Monitor Post-Translational Modifications and Degradation in Monoclonal Antibody Therapeutics 2020 ·Analytical Chemistry ·(unknown), (unknown), Thomas Powell, John F. O’Hara, Mariangela Spitali, Royston Goodacre, Andrew J. Doig	43
4	Subcritical Water Hydrolysis of Peptides: Amino Acid Side-Chain Modifications 2017 ·Journal of the American Society for Mass Spectrometry ·Thomas Powell, Steve Bowra, Helen J. Cooper	15
5	Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease 2015 ·Vaccines ·Patricia A. Jorquera, (unknown), Thomas Powell, Naveen Palath, James G. Boyd, Ralph A. Tripp	22
6	Human monoclonal antibodies from convalescent H7N9 patients in China and Taiwan 2014 ·Immunology ·Pramila Rijal, (unknown), Lisa Schimanski, Thomas Powell, (unknown), Tina T. X. Dong, (unknown), Alain Townsend	2
7	Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease 2013 ·PLoS ONE ·Patricia A. Jorquera, Youngjoo Choi, (unknown), Thomas Powell, James G. Boyd, Naveen Palath, Lia M. Haynes, Larry J. Anderson, Ralph A. Tripp	49
8	A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF) 2012 ·Journal of Biological Chemistry ·Fengwei Bai, Oluwatoyin A. Asojo, Pier F. Cirillo, (unknown), Michel Ledizet, Paul A. Aristoff, Lin Leng, Raymond A. Koski, Thomas Powell, Richard Bucala, Karen Anthony	61
9	Synthetic LbL nanoparticle vaccines containing the chemokine mimic epitope of RSV-G protein and a CD8 epitope of RSV-M2 protein elicit broad-based cellular and humoral responses (155.7) 2011 ·The Journal of Immunology ·Thomas Powell, James G. Boyd, Alice K. Jacobs, Naveen Palath, Mary DeRome, Jie Tang, (unknown), Jennifer L. Harcourt, Lia M. Haynes, (unknown), Ralph A. Tripp	1
10	Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo 2010 ·Vaccine ·Thomas Powell, Naveen Palath, Mary DeRome, Jie Tang, Alice K. Jacobs, James G. Boyd	29
11	Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs 2008 ·PLoS ONE ·Langzhou Song, Valerian Nakaar, Uma Kavita, Albert Price, (unknown), Jie Tang, Alice K. Jacobs, Ge Liu, Yan Huang, Priyanka Desai, (unknown), Virginia Takahashi, Scott Umlauf, Lucia Reiserová, Rodney Bell, Hong Li, Yi Zhang, William F. McDonald, Thomas Powell, Lynda Tussey	95
12	A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity 2007 ·The Journal of Infectious Diseases ·William F. McDonald, James W. Huleatt, Harald G. Foellmer, (unknown), Jie Tang, Priyanka Desai, Albert Price, Alice K. Jacobs, Virginia Takahashi, Yan Huang, Valerian Nakaar, Lena Alexopoulou, Erol Fikrig, Thomas Powell	150
13	Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin 2007 ·Vaccine ·James W. Huleatt, Valerian Nakaar, Priyanka Desai, Yan Huang, (unknown), Alice K. Jacobs, Jie Tang, William F. McDonald, Langzhou Song, Robert K. Evans, Scott Umlauf, Lynda Tussey, Thomas Powell	318
14	Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity 2006 ·Vaccine ·James W. Huleatt, (unknown), Jie Tang, Priyanka Desai, Elizabeth B. Kopp, Yan Huang, Langzhou Song, Valerian Nakaar, Thomas Powell	236
15	A Tumor-Derived Protein which Provides T-Cell Costimulation through Accessory Cell Activation 1995 ·Journal of Immunotherapy ·Thomas Powell, Randall Schreck, (unknown), (unknown), Audie Rice, Harald App, Mohammad Azam, Axel Ullrich, (unknown)	49
16	Moloney leukemia virus-induced cell surface antigen mimicry by monoclonal antibodies 1995 ·Immunologic Research ·(unknown), Thomas Powell, R V Srinivas, Meenal Elliott, E W Lamon	1
17	Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells 1993 ·Transplant Immunology ·(unknown), James A. Matriano, Thomas Powell, J. Wayne Streilein	2
18	Influence of I‐E expression on induction of neonatal transplantation tolerance 1991 ·European Journal of Immunology ·J. Wayne Streilein, (unknown), Thomas Powell	9
19	Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. 1990 ·The Journal of Immunology ·Thomas Powell, J. Wayne Streilein	106
20	Activation of a functional idiotype network response by monoclonal antibody specific for a virus (M-MuLV)-induced tumor antigen. 1988 ·The Journal of Immunology ·Thomas Powell, (unknown), Meenal Vakil, John F. Kearney, E W Lamon	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact